With this approach, the canonical cancer cells SK‐BR‐3, MCF‐7, and MDA‐MB‐231, maintain their characteristic expression of markers (i.e., ERα, HER2, and PGR) while developing distinct morphology. This evidence concerns the gene PGR and cancer.